Medication adherence to sodium‐glucose cotransporter‐2 inhibitors versus glucagon‐like peptide‐1 receptor agonists: A meta‐analysis
Diabetes, Obesity and Metabolism · 2024-10 · 26 (10) · 4544-4550
DOI: 10.1111/dom.15809 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 23.07.2024. Verfasst von Conner E Johnson und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of South Carolina School of Medicine Greenville, Greenville, South Carolina, USA. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2, Hypoglycemic Agents, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Aim To perform a meta‐analysis comparing real‐world medication adherence to sodium–glucose cotransporter‐2 inhibitors (SGLT2is) versus glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs). Materials and Methods A systematic search of Medline and Embase was conducted through October 2023. To meet inclusion criteria, articles had to be published in full text form and directly compare medication adherence to SGLT2is versus GLP‐1RAs in adults. Only studies evaluating real‐world data and utilizing the proportion of days covered (PDC) to measure adherence were included. Non‐adherence, defined as the proportion of patients with a PDC
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of South Carolina School of Medicine Greenville, Greenville, South Carolina, USA.
ORCID-Profile: Erin R Weeda
Zitieren
APA
Johnson, C. E., Sussman, W. B., & Weeda, E. R. (2024). Medication adherence to sodium‐glucose cotransporter‐2 inhibitors versus glucagon‐like peptide‐1 receptor agonists: A meta‐analysis. Diabetes, Obesity and Metabolism, 26(10), 4544-4550. https://doi.org/10.1111/dom.15809
Vancouver
Johnson CE, Sussman WB, Weeda ER. Medication adherence to sodium‐glucose cotransporter‐2 inhibitors versus glucagon‐like peptide‐1 receptor agonists: A meta‐analysis. Diabetes, Obesity and Metabolism. 2024;26(10):4544-4550. doi:10.1111/dom.15809
BibTeX
@article{Johnson2024,
author = {Johnson, Conner E and Sussman, Whitney B and Weeda, Erin R},
title = {Medication adherence to sodium‐glucose cotransporter‐2 inhibitors versus glucagon‐like peptide‐1 receptor agonists: A meta‐analysis},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
volume = {26},
number = {10},
pages = {4544--4550},
doi = {10.1111/dom.15809}
}
EUVIMED